Indian Pharma's Future Lies in Quality, Innovation and API Self-Reliance
As India’s pharmaceutical sector shifts from volume-driven growth to global-grade quality and compliance, Arpit Bhatia, Director, Laborate Pharmaceuticals, discusses evolving manufacturing standards, regulatory credibility, technology adoption and self-reliance in APIs, with Pharma Industrial India. He also highlights sustainability, transparency and innovation as key pillars shaping India’s ambition to become the pharmacy of the world.
Laborate Pharmaceuticals | 21/04/2026
Why Manufacturing Discipline is Becoming a True Differentiator in Generic Pharmaceuticals
Discipline has become the real competitive advantage in generic pharmaceuticals, overtaking scale, speed and low cost as the main drivers of success.
Laborate Pharmaceuticals | 29/01/2026
Laborate Pharmaceuticals Sets Ambitious Goal to Double Its Scale Within Five Years
Arpit Bhatia, Director of Laborate Pharmaceuticals, discusses the company’s forward-looking strategies to broaden its therapeutic portfolio, strengthen global competitiveness, and embrace digital transformation across its operations. He also sheds light on the vision behind Aqualab, Laborate’s new direct-to-retail (D2R) division.
Laborate Pharmaceuticals | 09/10/2025
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy